ArticleCancer cell international2021

miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells.

Narjes Jafari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.